Phase II data for Bexxar

Coulter (CLTR) and partner SmithKline Beecham (LSE:SB; SBH) announced data from a Phase II trial of Bexxar

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE